SEC Form 4 · accession 0001161697-18-000296
CATALYST PHARMACEUTICALS, INC. · CPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald A Denkhaus
Director
Period of report
May 30, 2018
Accepted (ET)
May 31, 2018 · 11:57 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369568
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 per share | May 30, 2018 | P | 20,000 | $3.75 | A | 120,000 | D |
Table II — derivative securities
No Table II lines on this filing.